Skip to main content
. Author manuscript; available in PMC: 2015 Dec 15.
Published in final edited form as: Int J Cancer. 2014 May 12;135(12):2878–2886. doi: 10.1002/ijc.28929

Table 2.

Expression of markers in the tumor center and invasion front detected by immunohistochemistry, stage UICC II: lymph node negative colon carcinomas, stage UICC III: lymph node positive colon carcinomas, values are presented as percent positive tumor cells. The p value is calculated by the two-sample Wilcoxon test. Significant proteins are shown in bold.

UICC II Mean (median); % UICC III Mean (median); % p
Tumor center
IGF1-R 79 (85) 82 (80) 0.42
MX1 13 (5) 17 (17) 0.19
DNAJA2 92(95) 87 (95) 0.76
IRF2BP1 69 (75) 17 (0) 0.008
DNAJB11 78 (90) 69 (80) 0.47
Invasion front
IGF1-R 84 (90) 89 (90) 0.007
MX1 24 (7.5) 46 (47.5) 0.02
DNAJA2 93 (95) 86 (90) 0.12
IRF2BP1 62 (80) 37 (0) 0.04
DNAJB11 81 (90) 83 (80) 0.60